A Study to Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease Patients
Clinical trial NCT00563355 · COMPLETED
Trial details
- NCT number
- NCT00563355
- Sponsor
- Hospital Authority, Hong Kong
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2001-02-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.